Open access peer-reviewed Edited Volume

Tyrosine Kinases as Druggable Targets in Cancer

Edited by Huan Ren

Southern University of Science and Technology, Shenzhen

Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL in chronic myeloid leukemia (CML), has revolutionized disease management. In this book, we examine a few aspects of PTKs and cancer, considering efficacy, predictive markers to therapeutic response, limitations, and future directions in TKI treatment. In this rapidly evolving field, overcoming therapeutic resistance is most challenging, and multi-targeting directs the next-generation TKIs and combination therapy as ongoing strategies in cancer treatment.

Read more >Order hardcopy
Tyrosine Kinases as Druggable Targets in CancerEdited by Huan Ren

Published: September 25th 2019

DOI: 10.5772/intechopen.79884

ISBN: 978-1-78984-809-0

Print ISBN: 978-1-78984-808-3

eBook (PDF) ISBN: 978-1-83962-219-9

Copyright year: 2019

Books open for chapter submissions

4295 Total Chapter Downloads

5 Crossref Citations

3 Web of Science Citations

7 Dimensions Citations


Open access peer-reviewed

1. Introductory Chapter: Tyrosine Kinases as Drug Targets in Cancer Treatment

By Huan Ren


Open access peer-reviewed

2. Non-receptor Tyrosine Kinases Role and Significance in Hematological Malignancies

By Ana Azevedo, Susana Silva and José Rueff


Open access peer-reviewed

3. JAK, an Oncokinase in Hematological Cancer

By Carlota Recio, Haidée Aranda-Tavío, Miguel Guerra-Rodríguez, Mercedes de Mirecki-Garrido, Patricia Martín-Rodríguez, Borja Guerra and Leandro Fernández-Pérez


Open access peer-reviewed

4. Noncoding RNAs as Predictive Biomarkers of Therapeutic Response to Tyrosine Kinase Inhibitors in Metastatic Cancer

By Julia Kovacova and Ondrej Slaby


Open access peer-reviewed

5. Cancer Management by Tyrosine Kinase Inhibitors: Efficacy, Limitation, and Future Strategies

By Venice Wing Tung Ho, Hor Yue Tan, Ning Wang and Yibin Feng


Edited Volume and chapters are indexed in

  • Worldcat
  • OpenAIRE
  • Google Scholar
  • AZ ebsco
  • Base
  • CNKI

Order a hardcopy of the Edited Volume

Free shipping with DHL Express

Hardcover (ex. VAT)£119

Order now

Residents of European Union countries need to add a Book Value-Added Tax Rate based on their country of residence. Institutions and companies, registered as VAT taxable entities in their own EU member state, will not pay VAT by providing IntechOpen with their VAT registration number. This is made possible by the EU reverse charge method.

Special discount for IntechOpen contributors

All IntechOpen contributors are offered special discounts starting at 40% OFF available through your personal dashboard

Login and purchase